Tuberculosis is the leading infectious disease killer globally due to a single pathogen.
Despite wide deployment of standard drug regimens, modern diagnostics and a vaccine …

BCG turns 100 this year and while it might not be the perfect vaccine, it has certainly
contributed significantly towards eradication and prevention of spread of tuberculosis (TB) …

COVID-19 remains a stark health threat worldwide, in part because of minimal levels of
targeted vaccination outside high-income countries and highly transmissible variants …

The tuberculosis (TB) vaccine Bacillus Calmette‐Guérin (BCG) was introduced 100 years
ago, but as it provides insufficient protection against TB disease, especially in adults, new …

ABSTRACT Bacillus Calmette-Guérin (BCG), the nonpathogenic Mycobacterium bovis strain
used as tuberculosis vaccine, has been successfully used as treatment for non-muscle …

Vaccination strategies against mycobacteria, focusing mostly on classical T‐and B‐cells,
have shown limited success, encouraging the addition of alternative targets. Classically …

A recent clinical trial demonstrated that Bacille Calmette-Guérin (BCG) revaccination of
adolescents reduced the risk of sustained infection with Mycobacterium tuberculosis (M. tb) …

While vaccines traditionally have been designed and used for protection against infection or
disease caused by one specific pathogen, there are known off-target effects from vaccines …

In 2021, most of the world was reasonably still concerned about the COVID-19 pandemic,
how cases were up and down in different countries, how the vaccination campaigns were …

Immunization strategies against tuberculosis (TB) that confer better protection than neonatal
vaccination with the 101-year-old Bacille Calmette-Guerin (BCG) are urgently needed to …